{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:52:15Z","timestamp":1790175135708,"version":"4.1.0"},"reference-count":56,"publisher":"SAGE Publications","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Human Gene Therapy"],"published-print":{"date-parts":[[2017,11]]},"abstract":"<jats:p>Gene therapy provides hope for a cure for patients with hemophilia by establishing continuous endogenous expression of factor VIII or factor IX following transfer of a functional gene copy to replace the hemophilic patient's own defective gene. Hemophilia may be considered a \u201clow-hanging fruit\u201d for gene therapy because a small increment in blood factor levels (\u22652% of normal) significantly improves the bleeding tendency from severe to moderate, eliminating most spontaneous bleeds. After decades of research, the first trial to provide clear evidence of efficiency after gene transfer in patients with hemophilia B using adeno-associated virus vectors was reported by the authors' group in 2011. This has been followed by unprecedented activity in this area, with the commencement of seven new early-phase trials involving &gt;55 patients with hemophilia A or hemophilia B. These studies have, in large part, generated promising clinical data that lay a strong foundation for gene therapy to move forward rapidly to market authorization. This review discusses the data from the authors' studies and emerging results from other gene therapy trials in both hemophilia A and B.<\/jats:p>","DOI":"10.1089\/hum.2017.167","type":"journal-article","created":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T02:06:10Z","timestamp":1503540370000},"page":"1004-1012","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":58,"title":["Advances in Gene Therapy for Hemophilia"],"prefix":"10.1177","volume":"28","author":[{"given":"Amit C.","family":"Nathwani","sequence":"first","affiliation":[{"name":"University College London Cancer Institute","place":["United Kingdom"]},{"name":"Royal Free London NHS Foundation Trust","place":["United Kingdom"]},{"name":"NHS Blood and Transplant","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Davidoff","sequence":"additional","affiliation":[{"name":"St. Jude Children's Research Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward G. D.","family":"Tuddenham","sequence":"additional","affiliation":[{"name":"University College London Cancer Institute","place":["United Kingdom"]},{"name":"Royal Free London NHS Foundation Trust","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2017,11,1]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2010.02383.x"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3536(11)80025-9"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.d01-1679.x"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.1996.7120126.x"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)78593-7"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23146"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1511769"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1703068"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3847"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.1.168.413k06_168_174"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0595-119"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.21.11563"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V63.2.451.451"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.24.10095"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200106073442301"},{"key":"e_1_3_2_17_2","first-page":"116a","article-title":"Implantation of non-viral ex vivo genetically modified autologous dermal fibroblasts that express B-domain deleted human factor VIII in 12 severe hemophilia A study subjects","volume":"100","author":"Roth DA","year":"2002","unstructured":"Roth DA, , Tawa NEJr, , Proper J, et al. Implantation of non-viral ex vivo genetically modified autologous dermal fibroblasts that express B-domain deleted human factor VIII in 12 severe hemophilia A study subjects. Blood, 2002; 100:116a.","journal-title":"Blood"},{"key":"e_1_3_2_18_2","first-page":"832","article-title":"Implantation of autologous skin fibroblast genetically modified to secrete clotting factor IX partially corrects the hemorrhagic tendencies in two hemophilia B patients","volume":"109","author":"Qiu X","year":"1996","unstructured":"Qiu X, , Lu D, , Zhou J, et al. Implantation of autologous skin fibroblast genetically modified to secrete clotting factor IX partially corrects the hemorrhagic tendencies in two hemophilia B patients. Chin Med J (Engl), 1996; 109:832\u2013839.","journal-title":"Chin Med J (Engl)"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2002.1.1"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3296"},{"key":"e_1_3_2_21_2","first-page":"154a","article-title":"Immune responses to AAV and to factor IX in a Phase I study of AAV-mediated liver-directed gene transfer for hemophilia B","volume":"102","author":"High KA","year":"2003","unstructured":"High KA, , Manno CS, , Sabatino DE, et al. Immune responses to AAV and to factor IX in a Phase I study of AAV-mediated liver-directed gene transfer for hemophilia B. Blood, 2003; 102:154a\u2013155a.","journal-title":"Blood"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-10-4035"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-03-010181"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.182412299"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1108046"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2010.274"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-10-3591"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V81.11.2925.2925"},{"key":"e_1_3_2_29_2","first-page":"S3","article-title":"Biosynthesis, assembly and secretion of coagulation factor VIII","volume":"8","author":"Kaufman RJ","year":"1997","unstructured":"Kaufman RJ, , Pipe SW, , Tagliavacca L, et al. Biosynthesis, assembly and secretion of coagulation factor VIII. Blood Coagul Fibrinolysis, 1997; 8:S3\u201314.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mt.6300308"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0809677105"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613369"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI34316"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2009.256"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.22.12725"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2006.05.004"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.5.1594.005k34_1594_1599"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1006\/mthe.2002.0607"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mt.6300268"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2008.292"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-282707"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3303080"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-10-462200"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05058.x"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2003.00708.x"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2006.01416.x"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH06-09-0510"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1358"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1006\/mthe.2001.0491"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2012.47"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-302729"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1142658"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1007-1111"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-386509-0.00012-0"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2008.61"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1089\/hgtb.2013.046"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3300937"}],"container-title":["Human Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/hum.2017.167","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/hum.2017.167","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/hum.2017.167","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:57:13Z","timestamp":1777449433000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/hum.2017.167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":56,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["10.1089\/hum.2017.167"],"URL":"https:\/\/doi.org\/10.1089\/hum.2017.167","relation":{},"ISSN":["1043-0342","1557-7422"],"issn-type":[{"value":"1043-0342","type":"print"},{"value":"1557-7422","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}